InvestorsHub Logo
Followers 617
Posts 93466
Boards Moderated 8
Alias Born 11/01/2006

Re: None

Saturday, 11/05/2016 5:57:33 PM

Saturday, November 05, 2016 5:57:33 PM

Post# of 20669
This pr was missed.

Inolife Technologies Obtains a $500,000 Financing

IRVINE, CA — (Marketwired) — 10/26/16 — Inolife Technologies Inc. (OTC PINK: INOLD), the emerging leader of needle free injection devices, announced today that it has obtained a $500,000 financing from the F. Bertucci Family Trust.

According to the terms of the agreement, Inolife has issued a convertible debenture in the amount of $500,000 U.S. and said debenture converts at any time during the term at a price of $1.00 per share. The convertible debenture is repayable on October 20, 2020 or before at the option of the company and shall pay an interest of 8% per annum to the holder. The interest is payable in common shares of the company at a price of $1.00 per share.

The closing of the transaction is October 27, 2016.

Following the closing of the transaction, Mr. Joe Bertucci, one of the beneficial owners of the trust, has accepted the nomination to the board of directors of the company. Mr. Bertucci is the President and CEO of Thomson Tremblay, a leading Canadian employment agency founded in 1971.

“We welcome Mr. Bertucci to our board, where his extensive entrepreneurial experience will greatly benefit the company in shaping our global vision,” said Mr. Michael Wright, President & CEO of Inolife Technologies Inc. “The investment is also very important at this stage of the commercialization of our needle free devices and will enable the company to build a sustainable business model and add significant value to our shareholders, and other stakeholders.”

You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!